BioCentury
ARTICLE | Clinical News

Reolysin: Completed Phase I enrollment

August 20, 2012 7:00 AM UTC

Oncolytics completed enrollment of 21 patients in the single-arm, dose-escalation U.S. Phase I REO 022 trial evaluating Reolysin in combination with FOLFIRI chemotherapy in patients with oxaliplatin-r...